A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence
Cells · 18.08.2025 · 14 (16) · 1279
DOI: 10.3390/cells14161279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 18.08.2025. Verfasst von Gabriella Guelfi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Università degli Studi di Perugia, 06126 Perugia, Italy. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, Dog Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Perugia - Italy, University of Perugia, Italy.
Abstract (Originalsprache)
Osteosarcoma (OS) and extraskeletal osteosarcoma (EOS) in dogs exhibit histological similarities but differ in anatomical origin, which poses a challenge to diagnostic accuracy. We adopted a marker-first strategy to enhance molecular classification by selecting RUNX2, KPNA2, and SATB2, three validated immunohistochemical (IHC) markers, as primary targets. Bioinformatic screening identified the miR-30 family as the only miRNA group predicted to coordinately regulate RUNX2, KPNA2, and SATB2, justifying its prioritization for expression analysis. RT-qPCR on FFPE tissues from 14 OS, 19 EOS, and 10 healthy controls revealed that miR-30a was significantly downregulated in OS and inversely correlated with RUNX2 nuclear expression, confirmed by IHC. MiR-30e also showed high diagnostic accuracy, while miR-30b and miR-30c distinguished EOS from OS. Non-seed interaction modeling (i.e., outside the canonical “seed” region, spanning nucleotides 2–8 of the miRNA) suggested divergent regulatory affinities within the PI3K/AKT/RUNX2 axis among miR-30 family members. MiR-30a and miR-30e exhibited the highest diagnostic power (LR+ 7.7 and 6.8, respectively), supporting their role as biomarkers. These results highlight a miR–30–centered regulatory axis with relevance for diagnosis and molecular stratification of canine osteogenic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine, Università degli Studi di Perugia, 06126 Perugia, Italy.
- Laboratory of Comparative Veterinary Histopathology, Istituto Zooprofilattico dell'Umbria e delle Marche (IZSUM) Togo Rosati, 06126 Perugia, Italy.
ORCID-Profile: Gabriella Guelfi, Camilla Capaccia, Ilaria Porcellato, Elisabetta Manuali, Margherita Maranesi, Leonardo Leonardi
Förderung
- University of Perugia - Italy
- University of Perugia, Italy
Zitieren
APA
Guelfi, G., Munteanu, P., Capaccia, C., Porcellato, I., Manuali, E., Maranesi, M., & Leonardi, L. (2025). A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence. Cells, 14(16), 1279. https://doi.org/10.3390/cells14161279
Vancouver
Guelfi G, Munteanu P, Capaccia C, Porcellato I, Manuali E, Maranesi M, et al. A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence. Cells. 2025;14(16):1279. doi:10.3390/cells14161279
BibTeX
@article{Guelfi2025,
author = {Guelfi, Gabriella and Munteanu, Petronela and Capaccia, Camilla and Porcellato, Ilaria and Manuali, Elisabetta and Maranesi, Margherita and Leonardi, Leonardo},
title = {A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence},
journal = {Cells},
year = {2025},
volume = {14},
number = {16},
pages = {1279},
doi = {10.3390/cells14161279}
}
EUVIMED